Provided by Tiger Trade Technology Pte. Ltd.

Ultragenyx Pharmaceutical

19.30
-0.0800-0.41%
Volume:3.66M
Turnover:70.88M
Market Cap:1.90B
PE:-3.31
High:19.77
Open:19.48
Low:19.13
Close:19.38
52wk High:42.37
52wk Low:18.29
Shares:98.32M
Float Shares:94.49M
Volume Ratio:1.58
T/O Rate:3.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8316
EPS(LYR):-5.8316
ROE:-608.47%
ROA:-22.03%
PB:-23.72
PE(LYR):-3.31

Loading ...

Oct 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Oct 07, 2021

Major Issues Report

8-K - Current report
Sep 27, 2021

Major Issues Report

8-K - Current report
Aug 12, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 03, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 02, 2021

Major Issues Report

8-K - Current report
Jun 30, 2021

Major Issues Report

8-K - Current report
Jun 25, 2021

Major Issues Report

8-K - Current report
Jun 10, 2021

Major Issues Report

8-K - Current report
May 19, 2021

Major Issues Report

8-K - Current report
May 14, 2021

Major Issues Report

8-K - Current report
May 07, 2021

Major Issues Report

8-K - Current report
May 05, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2021

Major Issues Report

8-K - Current report
Apr 16, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]